Neurodegenerative diseases are conditions that cause progressive decline in cognitive, emotional, and motor functions. The damage progresses over time and leads to death. This can include Alzheimer’s, Parkinson’s, Huntington’s, Lou Gehrig’s (ALS), and Multiple Sclerosis. Neurodegenerative diseases can be caused by genetics, lifestyle, or environmental factors. These diseases are complex and differ from other forms of dementia in that the brain cells lose their structure and functioning. As a result, the processes that help us think or control our muscles become impaired. Unfortunately, there is no cure for any of these diseases yet, though much research is being done to understand them better. The most common symptoms associated with neurodegenerative disease states (NDDS) include changes in mood or behavior, difficulty speaking or moving, difficulties with memory and learning, and changes in personality. As the disease progresses, individuals may eventually become unable to care for themselves. This is why early detection and diagnosis are essential in helping to treat NDDS. There are a few treatments that can be used to slow down the progression of NDDS, such as physical therapy, medication, and lifestyle modifications. Medication is usually the first line of treatment, with many drugs focusing on tackling various symptoms, such as memory loss and muscle control. Additionally, physical therapy can help improve the person’s mobility and balance, while lifestyle modifications can help to reduce stress and improve quality of life. Unfortunately, people with NDDS will ultimately succumb to the neurological damage that accumulates over time. For this reason, it is important to provide supportive care and be available to someone living with NDDS. This includes helping them communicate their needs to caregivers, providing physical, occupational, or speech therapy, and offering emotional support. It is also important for loved ones to stay informed and remain up-to-date on treatment options and technological advances. Ultimately, understanding this devastating illness is the first step in helping individuals and families impacted by Neurodegenerative Disease states. It is essential that research continues in order to develop treatments that can give people hope and the means to manage and improve the quality of their lives.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Neurojourney: A free, digital, and multilingual anticipatory guidance tool for parents and clinicians caring for children with severe neurological impairment
Blyth Lord, Courageous Parents Network, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States